comparemela.com

Latest Breaking News On - Gland pharma q2 results - Page 1 : comparemela.com

Gland Pharma soars 5% on in-line Q2 results; should buy, hold or sell the stock?

Gland Pharma earnings have bottomed out and are on track to recovery with stable pricing and volume-led growth across geographies, said Jefferies.

France
India
French
Motilal-oswal
Gland-pharma
Rocuronium-bromide
Enoxaparin-sodium
Micafungin-sodium
Upside-scenario
Gland-pharma-q2-earnings
Land-pharma-q2-earnings-news

Gland Pharma Q2 results: Net Profit down 20% to Rs 194 crore

Gland Pharma had reported a 15.3 percent year-on-year (YoY) drop in net profit at Rs 194.1 crore for the first quarter ended June 30

China
India
France
Srinivas-sadu
Gland-pharma
Gland-pharma-q2-earnings
Gland-pharma-q2-results
Land-pharma-q2-earnings-updates
Land-pharma-q2-results-updates
Land-pharma-quarterly-results
Land-pharma-q2-profit

Gland Pharma shares plunge 12% today: Should you buy, hold or sell?

Kotak said the near-term outlook for Gland Pharma is sluggish but the product pipeline and entry into new markets provide medium-term growth visibility.

China
Nirmal
Andhra-pradesh
India
Udayan-mukherjee
Motilal-oswal
Gland-pharma
Nirmal-bang-institutional
Institutional-equities
Indus-towers
Tata-chemicals

Gland Pharma to announce four complex injectables during FY22; Q2 profit rises 38%

Announcing the Q2 FY22 financial results, CEO Srinivas Sadu stated that Gland Pharma is on track to make four complex injectable filing during the current financial year

Srinivas-sadu
Gland-pharma
Gland-pharma-complex-injectables
Gland-pharma-q2-results
Gland-pharma-profit
Gland-pharma-result
Gland-pharma-shares

vimarsana © 2020. All Rights Reserved.